Relative incidence of seizures in risk periods compared with first control period (day 90-31 before vaccination) for people with epilepsy and with seizures (n=738) and for people without epilepsy but with seizures (n=121) for all episodes, all doses, and inpatient and outpatient seizures
| With epilepsy and seizures (n=738) | Without epilepsy, with seizures (n=121) | ||||
|---|---|---|---|---|---|
| No of seizures | Relative incidence (95% CI) | No of seizures | Relative incidence (95% CI) | ||
| Main model | |||||
| Risk period: | |||||
| Day 1-7 | 41 | 0.95 (0.69 to 1.32) | 5 | 0.99 (0.39 to 2.53) | |
| Day 8-30 | 131 | 0.94 (0.77 to 1.16) | 27 | 1.64 (0.99 to 2.71) | |
| Model including buffer period (30-1 days before vaccination) | |||||
| Buffer period | 200 | 1.26 (1.06 to 1.50) | 28 | 1.56 (0.95 to 2.56) | |
| Risk period: | |||||
| Day 1-7 | 41 | 0.96 (0.69 to 1.33) | 5 | 0.97 (0.38 to 2.47) | |
| Day 8-30 | 131 | 0.95 (0.77 to 1.16) | 27 | 1.61 (0.97 to 2.65) | |
| Control period: | |||||
| Day 31-90 | 297 | 0.89 (0.76 to 1.05) | 72 | 1.88 (1.26 to 2.80) | |